Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
9
Number of overlapping holdings
8.0%
% of IXJ's 113 holdings also in OZEM
42.9%
% of OZEM's 22 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.6% | 16.9% | 9.6% |
 |
ROCHE HOLDING LTD | 3.2% | 4.9% | 3.2% |
|
AMGEN INC | 2.2% | 3.0% | 2.2% |
|
PFIZER INC | 1.8% | 3.5% | 1.8% |
|
GILEAD SCIENCES INC | 1.9% | 1.8% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to OZEM
|
UNITEDHEALTH GROUP INC | 6.0% |
|
JOHNSON & JOHNSON | 5.5% |
|
ABBVIE INC | 4.4% |
|
ABBOTT LABORATORIES | 3.3% |
|
NOVARTIS AG | 3.2% |
 |
ASTRAZENECA PLC | 3.0% |
 |
NOVO NORDISK A/S-B | 2.9% |
|
MERCK & CO. INC. | 2.9% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
THERMO FISHER SCIENTIFIC INC | 2.4% |
IXJ Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -16.2% |
|
ELI LILLY & CO | -7.3% |
|
ZEALAND PHARMA A/S | -4.6% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.2% |
|
VIKING THERAPEUTICS, INC. | -4.1% |
 |
INNOVENT BIOLOGICS, INC. | -3.6% |
|
ALTIMMUNE, INC. | -3.6% |
 |
HANMI PHARM CO LTD | -3.1% |
|
ASTRAZENECA PLC-SPONS ADR | -3.1% |
|
TERNS PHARMACEUTICALS, INC. | -2.8% |